Accolade (ACCD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 9.09%. A quarter ago, it was expected that this company would post a loss of $0.46 per share when it actually produced a loss of $0.28, delivering a surprise of 39.13%. Over the last four quarters, the company has surpassed cons ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-K ____________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 29, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-393 ...

Exhibit 99.1 Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024 SEATTLE, April 25, 2024 -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether serving consumers, employers, health plans, or government entities, the core of our value proposition is making healthcare easier to access, navigate, and ...

公司背景 - Accolade, Inc. (NASDAQ:ACCD)被GlobalData称为“个性化医疗倡导公司”，致力于降低雇主的医疗成本并改善员工的健康和福利[1] 财务表现 - ACCD在2024财年第三季度的财务表现良好，最新文章分析了公司的最新发展和即将公布的业绩[1] - ACCD预计将于4月25日公布2024财年第四季度的业绩，市场对公司的收入增长和EBITDA的正面预期较高[12] - ACCD的财务表现预计将受到强劲的预订和正面运营杠杆效应的支持，有望在第四季度实现显著改善[14] 合作伙伴关系 - ACCD的新合作伙伴包括Kindbody（生育诊所运营商）和Brightline（儿童行为健康解决方案提供商），这些合作伙伴的加入为公司的合作伙伴网络增添了活力[3] - ACCD在健康护理领域的合作伙伴关系中专注于高医疗支出领域，这有助于吸引和留住雇主的人才[5] 技术应用 - ACCD利用人工智能技术提高客户价值和公司利润，例如通过监控客户服务质量和运营数据分析[9] 风险提示 - 投资者需要关注ACCD可能面临的下行风险，包括财务业绩不及预期、新合作伙伴服务不受欢迎以及人工智能带来的效益可能低于预期[15][16][17]

Accolade公司人工智能应用 - Accolade公司因在医疗保健领域应用自然语言处理技术而荣获2024年度人工智能卓越奖[1] - Accolade公司将人工智能和自然语言处理技术融入到关怀团队的支持中，以帮助数百万会员过上更健康的生活[2] - Accolade公司利用人工智能改进会员服务和数字健康结果，包括自动化任务，如笔记总结和呼叫路由，以使关怀团队完全专注于会员[3]

McDonald Harris assumes new role on Executive Leadership Team to deliver an exceptional employee experience and support the growth and development of its 2,400+ global workforce SEATTLE, March 19, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President. "Transforming healthcare in this country requires visionary human resources leaders who are willing to challenge the status quo," said Rajeev Singh, Chairman ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...

This week brought another blow for reproductive rights in the U.S. An Alabama Supreme Court handed down a ruling that not only can frozen embryos be classified as “children,” but destroying them can lead to charges of wrongful death. This decision has prompted the University of Alabama at Birmingham, the state’s largest healthcare provider, to cease all in vitro fertilization (IVF) treatments. For state residents seeking IVF treatments or similar medical procedures, this development promises to have signifi ...

ACCD公司股价表现 - ACCD上市公司股价在过去四周上涨了7.7%，但根据华尔街分析师设定的短期价格目标，股价仍有潜在上涨空间[1] - 分析师对ACCD股价走势的方向和幅度有高度一致看法，这可能是进一步研究的良好起点[7] ACCD公司盈利能力 - 分析师对ACCD公司的盈利能力持有强烈一致看法，认为公司有望报告比他们先前预测的更好的收益[4] ACCD公司股票评级 - ACCD目前拥有Zacks Rank 2（买入），这意味着它在我们根据与盈利预期相关的四个因素对4000多支股票进行排名中处于前20%[10]

Persistent earnings growth captivates almost everyone, from the top brass to research analysts. This is because earnings are a measure of the money a company is making. Still, earnings acceleration works even better when lifting the stock price. Studies have shown that most successful stocks have seen an acceleration in earnings before an uptick in the stock price. Earnings acceleration is the incremental growth in a company’s earnings per share (EPS). In other words, if the rate of a company’s quarter-over ...